Unsustainably high healthcare costs paint bleak long-term budget outlook

Share this article:
Financial outlook is grim for not-for-profits, analyst says
Financial outlook is grim for not-for-profits, analyst says

Despite curtails in federal healthcare costs, the state of the nation's budget remains grim, a government report finds.

Passage of the Affordable Care Act and the Budget Control Act of 2012 improved the budget outlook, but neither are enough to fix the gap between spending and revenue, according to a report by the Government Accountability Office.

“While the [Budget Control Act] improved the outlook, it did not eliminate the longer-term challenge, in part because it did not focus on the fundamental drivers of the government's future fiscal imbalances — a structural gap between revenues and spending driven by rising health care costs and demographics,” the report states.

Cost-control measures in the ACA will minimize the growth in money spent on federal health care. However, Medicare Trustees, the Congressional Budget Office and the Centers for Medicare & Medicaid Services actuary remain concerned about the sustainability of certain health care cost-control measures over the long term, the report states.

“For example, they note that reductions in physician payment rates scheduled to occur under current law have routinely been overridden,” the report states.

Click here to read the full report.

Share this article:

More in News

Large hepatitis outbreak reaches 47 cases, podiatry company denies ManorCare's charges

The number of people infected in an infamous North Dakota Hepatitis C outbreak has risen, state health officials say.

National Quality Forum supports quality measures in bill to standardize post-acute assessments

National Quality Forum supports quality measures in bill ...

The National Quality Forum has come out in strong support of a proposed standardized quality measures, such as skin integrity, across different types of post-acute care settings. Uniform assessments are ...

CMS changes mind on hospice drugs

The Centers for Medicaid & Medicare Services has revised guidance on authorization of hospice drugs for those under Medicare Advantage and Part D plans, according to a new memo.